Narrow Band-Ultraviolet B Versus Clobetasol Propionate Foam in the Treatment of Vitiligo: A Retrospective Study

    June 2013 in “ Dermatology and Therapy ”
    Giuseppe Stinco, Giusto Trevisan, Cinzia Buligan … Pasquale Patrone
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Current and emerging therapy for the management of vitiligo Clinical Cosmetic and Investigational Dermatology · 2009
    2. Efficacy And Safety Of A New Clobetasol Propionate 0.05% Foam In Alopecia Areata: A Randomized, Double-Blind Placebo-Controlled Trial Journal of the European Academy of Dermatology and Venereology · 2006
    3. Narrow‐band UVB for the treatment of vitiligo: an emerging effective and well‐tolerated therapy International Journal of Dermatology · 2004